SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: LLCF who wrote (339)8/3/1999 7:15:00 PM
From: smh  Read Replies (2) | Respond to of 52153
 
DAK,

I think it is worth noting that for the $87m Merck pays for SIBI, it gets;

$ 18m cash
+ 18m Cadus escrow
+ 63m tax loss carryforwards
+ 3m tax credits

Don't know exactly how much of the tax losses Merck can use, but how much did they pay for science, patents, licenses again??

BTW - thanks to you and Peter for your, as always, astute thoughts on hedging from the other day.

SMH